Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “vaccine”

821 pharma patents match "vaccine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 821
Index total 30,257
Page 21 / 35

Quick answer

This filtered view shows 821 pharmaceutical patents matching "vaccine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

821 results for “vaccine” · 30,257 patents in full index Clear search

  1. US 8790635

    Live, oral vaccine for protection against Shigella dysenteriae serotype 1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

  2. US 8790652

    Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules to inhibit angiogenesis

    VACCINEX, INC. · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

  3. US 8778671

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  4. US 8765141

    Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted

  5. US 8765146

    Adenoviral vector-based malaria vaccines

    United States of America as represented by the Secretary of the Air Force · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted

  6. US 8753646

    IPV-DPT vaccine

    Takeda Pharmaceutical Company Limited · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  7. US 8753649

    Polysaccharide-protein conjugate vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  8. US 8747859

    Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142

    The United States of America, as represented by the Secretary of Agriculture · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  9. US 8747863

    Vaccine for shigella

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  10. US 8741306

    Kidney specific tumor vaccine directed against kidney tumor antigen G-250

    The Regents of the University of California · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  11. US 8741309

    Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142

    The United States of America, as represented by the Secretary of Agriculture · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  12. US 8741313

    Polypeptide vaccine and vaccination strategy against mycobacterium

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  13. US 8734778

    Yeast-based vaccines as immunotherapy

    The Regents of the University of Colorado · Granted May 27, 2014 · Expires May 22, 2034

    granted

  14. US 8709813

    DNA promoters and anthrax vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  15. US 8710185

    Bacterial superantigen vaccines

    The United States of America as represented by the Secretary of the Army · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  16. US 8697856

    Plasmodium vivax hybrid circumsporozoite protein and vaccine

    The United States of America as represented by the Secretary of the Army · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  17. US 8668911

    Streptococcus vaccine compositions and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted

  18. US 8663622

    Recombinant vaccine viruses expressing IL-15 and methods using the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  19. US 8647633

    Recombinant F1-V plague vaccine

    The United States of America as represented by the Secretary of the Army · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

  20. US 8647637

    Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs

    The Board of Regents for Oklahoma State University · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

  21. US 8637050

    Peptide vaccines against group A streptococci

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  22. US 8637026

    Anti-C35 antibody combination therapies and methods

    VACCINEX, INC. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  23. US 8637049

    Attenuated live vaccines for aquatic animals

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  24. US 8629260

    Anti-arthropod vector vaccines, methods of selecting and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.